Presentations and videos

Minimal residual disease in Myeloma Session 1
Minimal residual disease in Myeloma Session 2
Improving Survival in Multiple Myeloma
What’s new in Myeloma Treatment: a New Zealand Perspective
CAR T-cell Therapy: a New Frontier in Blood Cancer Treatment
Four Decades of Myeloma – Ken Romeril

Research and articles

Multiple Myeloma Research Review

Highlights include: • Anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma. • MGUS risk in relatives of patients with multiple myeloma. • Costs of peripheral neuropathy in patients treated for...
Continue Reading

Living well with Myeloma

This guide is written for people who have been diagnosed with myeloma. It will also be helpful for their families, friends and health professionals. It provides information about how to...
Continue Reading

Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing.

The treatment landscape for multiple myeloma has dramatically changed over the past decade with the introduction of several new classes of drugs, which are very effective at controlling the disease...
Continue Reading